381 related articles for article (PubMed ID: 20639142)
1. TPI 1020, a novel anti-inflammatory, nitric oxide donating compound, potentiates the bronchodilator effects of salbutamol in conscious guinea-pigs.
Turner DL; Ferrari N; Ford WR; Kidd EJ; Paquet L; Renzi P; Broadley KJ
Eur J Pharmacol; 2010 Sep; 641(2-3):213-9. PubMed ID: 20639142
[TBL] [Abstract][Full Text] [Related]
2. Bronchoprotection in conscious guinea pigs by budesonide and the NO-donating analogue, TPI 1020, alone and combined with tiotropium or formoterol.
Turner Dl; Ferrari N; Ford WR; Kidd EJ; Nevin B; Paquet L; Renzi P; Broadley KJ
Br J Pharmacol; 2012 Oct; 167(3):515-26. PubMed ID: 22563753
[TBL] [Abstract][Full Text] [Related]
3. Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.
Koskela HO; Kiviniemi V; Purokivi MK; Taivainen AH; Tukiainen HO
Respir Med; 2006 Oct; 100(10):1760-6. PubMed ID: 16563715
[TBL] [Abstract][Full Text] [Related]
4. Comparative effects of inhaled budesonide and the NO-donating budesonide derivative, NCX 1020, against leukocyte influx and airway hyperreactivity following lipopolysaccharide challenge.
Nevin BJ; Broadley KJ
Pulm Pharmacol Ther; 2004; 17(4):219-32. PubMed ID: 15219267
[TBL] [Abstract][Full Text] [Related]
5. In vivo bronchodilator action of a novel K+ channel opener, KC 399, in the guinea pig.
Imagawa J; Kamei K; Yoshida S; Sugo I; Koga T; Nabata H
J Pharmacol Exp Ther; 1994 Apr; 269(1):1-6. PubMed ID: 8169816
[TBL] [Abstract][Full Text] [Related]
6. A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.
Lagente V; Naline E; Guenon I; Corbel M; Boichot E; Burgaud JL; Del Soldato P; Advenier C
J Pharmacol Exp Ther; 2004 Jul; 310(1):367-75. PubMed ID: 15084649
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo pharmacological characterization of 5-[(R)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one (indacaterol), a novel inhaled beta(2) adrenoceptor agonist with a 24-h duration of action.
Battram C; Charlton SJ; Cuenoud B; Dowling MR; Fairhurst RA; Farr D; Fozard JR; Leighton-Davies JR; Lewis CA; McEvoy L; Turner RJ; Trifilieff A
J Pharmacol Exp Ther; 2006 May; 317(2):762-70. PubMed ID: 16434564
[TBL] [Abstract][Full Text] [Related]
8. Effect of beta 2-adrenoceptor agonists against platelet-activating factor-induced airway microvascular leakage and bronchoconstriction in the guinea pig.
Sakamoto T; Barnes PJ; Chung KF
Agents Actions; 1993 Sep; 40(1-2):50-6. PubMed ID: 7908496
[TBL] [Abstract][Full Text] [Related]
9. Beta-adrenoceptor responses of the airways: for better or worse?
Broadley KJ
Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
[TBL] [Abstract][Full Text] [Related]
10. Salbutamol-induced airway hyperreactivity in guinea pigs is not due to a loss of its bronchodilator effect.
Buchheit KH; Hofmann A; Fozard JR
Eur J Pharmacol; 1995 Dec; 287(1):85-8. PubMed ID: 8666031
[TBL] [Abstract][Full Text] [Related]
11. Effects of nebulised magnesium sulphate on inflammation and function of the guinea-pig airway.
Turner DL; Ford WR; Kidd EJ; Broadley KJ; Powell C
Eur J Pharmacol; 2017 Apr; 801():79-85. PubMed ID: 28284753
[TBL] [Abstract][Full Text] [Related]
12. beta2-Adrenoceptor desensitization in human alveolar macrophages induced by inhaled terbutaline in vivo is not counteracted by budesonide.
Zetterlund A; Hjemdahl P; Larsson K
Clin Sci (Lond); 2001 Apr; 100(4):451-7. PubMed ID: 11256987
[TBL] [Abstract][Full Text] [Related]
13. Dose-related protection against histamine-induced bronchoconstriction by inhaled salmeterol.
Maconochie JG; Denyer LH; Hassani H
Int J Clin Pharmacol Ther; 1994 Jul; 32(7):329-34. PubMed ID: 7952793
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
Sin DD; Man SF
Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
[TBL] [Abstract][Full Text] [Related]
15. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma.
Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP
Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530
[TBL] [Abstract][Full Text] [Related]
16. A study of mechanisms underlying amitriptyline-induced acute lung function impairment.
Svens K; Ryrfeldt A
Toxicol Appl Pharmacol; 2001 Dec; 177(3):179-87. PubMed ID: 11749117
[TBL] [Abstract][Full Text] [Related]
17. Positive interaction of the beta2-agonist CHF 4226.01 with budesonide in the control of bronchoconstriction induced by acetaldehyde in the guinea-pigs.
Rossoni G; Manfredi B; Razzetti R; Civelli M; Bongrani S; Berti F
Br J Pharmacol; 2005 Feb; 144(3):422-9. PubMed ID: 15655502
[TBL] [Abstract][Full Text] [Related]
18. Prevention of bronchoconstriction in sensitized guinea pigs: efficacy of common prophylactic drugs.
Schütz N; Peták F; Barazzone-Argiroffo C; Sly PD; Habre W
Respir Physiol Neurobiol; 2004 Jul; 141(2):167-78. PubMed ID: 15239967
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
20. Relaxation and potentiation of cGMP-mediated response by ibudilast in bovine tracheal smooth muscle.
Nakahara T; Yunoki M; Moriuchi H; Mitani A; Sakamoto K; Ishii K
Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):262-9. PubMed ID: 12172709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
